← Leaderboards
Jimmy J Hwang
Georgetown University
$524,979
Attributed
$524,979
Total exposure
5
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $394.4K · FY2005–07$500K$375K$250K$125K$0
'05
'06
'07
Funding mix
By agency
NIH$524,979 · 5
By mechanism
M01$524,979 · 5
Top collaborators
No co-investigators on record.
Most similar at Georgetown University
Same institution · by research overlap
- John L. Marshall$2,076,333
- Kevin J Cullen$20,041,785
- Nita L. Seibel$34,818
- Daniel F. Hayes$1,994,971
- Insoo Bae$570,751
Others in their field
Top investigators on “Clinical Trial Phase I”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Lawrence Corey · Fred Hutchinson Cancer Center$674,722,986
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$549,289,302
- Barton F Haynes · Duke University$532,133,792
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$407,280,377
Research focus
Clinical Trial Phase IDrug Screening /EvaluationNeoplasm /Cancer ChemotherapyChemotherapyClinical Trial Phase IiClinical Trials, Phase IiComputer Retrieval Of Information On Scientific Projects DatabaseCombination ChemotherapyEvaluationCsf3 GeneDocetaxelDocetaxel/OxaliplatinDosageDoseDrug KineticsCohortEnd PointEndpoint DeterminationClinical ResearchFundingGrantHuman SubjectHuman Therapy EvaluationAntitumor Agent
Grant awards (5)
PHASE I TRIAL OF DOCETAXEL AND OXALIPLATIN IN ADVANCED SOLID TUMORS$34,007
M01 · FY2007 · RR · contact PI
PHASE I TRIAL OF DOCETAXEL AND OXALIPLATIN IN ADVANCED SOLID TUMORS$95,512
M01 · FY2006 · RR · contact PI
VACCINIA-CEA(6D)-TRICOM &FOWLPOX-CEA(6D)-TRICOM W/GM-CSF &DOCETAXEL IN CANCER$391,821
M01 · FY2005 · RR
CALPGB 60101: A PHASE1 STUDY OSI-774 FOR SOLID TUMORS$2,587
M01 · FY2005 · RR
Phase I trial of docetaxel and oxaliplatin in advanced solid tumors$1,052
M01 · FY2004 · RR